000 | 05461nam a22004695i 4500 | ||
---|---|---|---|
001 | 978-3-319-39658-3 | ||
003 | DE-He213 | ||
005 | 20180206183143.0 | ||
007 | cr nn 008mamaa | ||
008 | 161109s2016 gw | s |||| 0|eng d | ||
020 |
_a9783319396583 _9978-3-319-39658-3 |
||
050 | 4 | _aQR177 | |
072 | 7 |
_aMMG _2bicssc |
|
072 | 7 |
_aMED071000 _2bisacsh |
|
082 | 0 | 4 |
_a616.9041 _223 |
245 | 1 | 0 |
_aEfflux-Mediated Antimicrobial Resistance in Bacteria _h[recurso electrónico] : _bMechanisms, Regulation and Clinical Implications / _cedited by Xian-Zhi Li, Christopher A. Elkins, Helen I. Zgurskaya. |
264 | 1 |
_aCham : _bSpringer International Publishing : _bImprint: Adis, _c2016. |
|
300 |
_aXXI, 848 p. 72 illus., 61 illus. in color. _bonline resource. |
||
336 |
_atext _btxt _2rdacontent |
||
337 |
_acomputer _bc _2rdamedia |
||
338 |
_aonline resource _bcr _2rdacarrier |
||
347 |
_atext file _bPDF _2rda |
||
505 | 0 | _aI-Bacterial drug efflux pumps: structures and transport mechanisms -- 1.Structures and transport mechanisms of RND efflux pumps -- 2.Structural and molecular landscape of MFS and MATE efflux pumps -- 3.Small multidrug resistance efflux pumps -- 4.Structures and transport mechanisms of the ABC efflux pumps -- 5.Multidrug efflux in the context of two-membrane cell envelopes -- II-Bacterial drug efflux pumps in antimicrobial resistance: substrates, regulation and clinical significance -- 6.Antimicrobial resistance in bacteria: an overview of mechanisms and role of drug efflux pumps -- 7.Antimicrobial drug efflux pumps in Staphylococcus aureus -- 8.Antimicrobial drug efflux pumps in other Gram-positive bacteria -- 9.Antimicrobial drug efflux pumps in Escherichia coli -- 10.Antimicrobial drug efflux pumps in Salmonella -- 11.Antimicrobial drug efflux pumps in Enterobacter and Klebsiella -- 12.Antimicrobial resistance and drug efflux pumps in Vibrio and Legionella -- 13.Antimicrobial resistance and drug efflux pumps in Acinetobacter -- 14.Antimicrobial drug efflux pumps in Pseudomonas aeruginosa -- 15.Antimicrobial drug efflux pumps in Stenotrophomona maltophilia -- 16.Antimicrobial drug efflux pumps in Burkholderia -- 17.Efflux pumps in Neisseria gonorrhoeae: contributions to antimicrobial resistance and virulence -- 18.Efflux pumps in Campylobacter: key players for antimicrobial resistance and environmental adaption -- 19.Antimicrobial resistance and drug efflux pumps in Helicobacter -- 20.Antimicrobial resistance and drug efflux pumps in Bacteroides -- 21.Efflux pumps in mycobacteria: antimicrobial resistance, physiological functions, and role in pathogenicity -- 22.Antimicrobial drug efflux genes and pumps in bacteria of animal and environmental origin -- 23.Role of plasmid-encoded drug efflux pumps in antimicrobial resistance -- 24.Influence of regulatory RNAs on antimicrobial resistance and efflux mechanisms -- III.Role of drug efflux pumps beyond antimicrobial resistance: natural functions -- 25.The relationship between bacterial multidrug efflux pumps and biofilm formation -- 26.Antimicrobial drug efflux systems as components of bacterial stress responses -- 27.Involvment of antimicrobial drug efflux systems in bacterial fitness and virulence -- IV. Antimicrobial development and efflux pump inhibitors -- 28.Impact of antimicrobial drug efflux pumps on antimicrobial discovery and development -- 29.Antimicrobial drug efflux pump inhibitors -- 30.Multidrug efflux pumps and their inhibitors characterized by computational modeling. | |
520 | _aThis book, written by leading international experts, provides a comprehensive, current examination of transport-mediated antimicrobial resistance. As a particularly powerful mechanism of multidrug resistance, an in-depth examination of efflux pumps is conducted with bacteria of major public health concern including Enterobacteriaceae, Acinetobacter, Neisseria, Pseudomonas, staphylococci, and mycobacteria. The content spans structural biochemistry and transport mechanisms of the major transporter families and considers individual drug efflux systems across various Gram-positive and Gram-negative species. Genomic analysis of efflux pump distribution and their contribution to clinically-relevant resistance are a major focus of the text. Moreover, interplay between drug efflux pumps and other key resistance mechanisms such as intrinsic drug impermeability, inactivation, and target alterations are discussed, as well as their molecular expression-based regulation and physiological functions beyond resistance, involving biofilms, stress response, and pathogenicity. Finally, strategies are addressed to target this drug resistance mechanism with novel antimicrobials or drug inhibitor adjuvants. | ||
650 | 0 | _aMedicine. | |
650 | 0 | _aDrug resistance. | |
650 | 0 | _aInfectious diseases. | |
650 | 1 | 4 | _aBiomedicine. |
650 | 2 | 4 | _aDrug Resistance. |
650 | 2 | 4 | _aInfectious Diseases. |
700 | 1 |
_aLi, Xian-Zhi. _eeditor. |
|
700 | 1 |
_aElkins, Christopher A. _eeditor. |
|
700 | 1 |
_aZgurskaya, Helen I. _eeditor. |
|
710 | 2 | _aSpringerLink (Online service) | |
773 | 0 | _tSpringer eBooks | |
776 | 0 | 8 |
_iPrinted edition: _z9783319396569 |
856 | 4 | 0 |
_zLibro electrónico _uhttp://148.231.10.114:2048/login?url=http://dx.doi.org/10.1007/978-3-319-39658-3 |
912 | _aZDB-2-SBL | ||
942 | _cLIBRO_ELEC | ||
999 |
_c227981 _d227981 |